Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach (Q22305854)
Jump to navigation
Jump to search
scientific article
- Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach |
scientific article |
|
Statements
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach (English)
0 references
Claudio Gasperini
1 reference
Ruggieri
1 reference
July 2012
0 references
19 July 2012
4 references
25 April 2019
30 June 2019
7 November 2019
26 October 2020
4 references
25 April 2019
30 June 2019
7 November 2019
26 October 2020
6
0 references
175
0 references
1 reference
1 reference